Publication

Heart failure highlights in 2012-2013

Liu, L. C. Y., Damman, K., Lipsic, E., Maass, A. H., Rienstra, M. & Westenbrink, B. D., Feb-2014, In : European Journal of Heart Failure. 16, 2, p. 122-132 11 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Heart failure has become the cardiovascular epidemic of the century. The European Journal of Heart Failure is dedicated to the advancement of knowledge in the field of heart failure management. In 2012 and 2013, several pioneering scientific discoveries and paradigm-shifting clinical trials have been published. In the current paper, we will discuss the most significant novel insights into the pathophysiology, diagnosis, and treatment of heart failure that were published during this period. All relevant research areas are discussed, including pathophysiology, co-morbidities, arrhythmias, biomarkers, clinical trials, and device therapy, including left ventricular assist devices.

Original languageEnglish
Pages (from-to)122-132
Number of pages11
JournalEuropean Journal of Heart Failure
Volume16
Issue number2
Publication statusPublished - Feb-2014

    Keywords

  • Heart failure, Highlights 2012/13, Pathophysiology, Co-morbidities, Atrial fibrillation, Biomarkers, Pharmacological therapy, Interventional treatment, CRT, Assist devices, CARDIAC-RESYNCHRONIZATION THERAPY, PRESERVED EJECTION FRACTION, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, LEFT-VENTRICULAR DYSFUNCTION, MINERALOCORTICOID RECEPTOR ANTAGONIST, MECHANICAL CIRCULATORY SUPPORT, RANDOMIZED CONTROLLED-TRIAL, DIRECT RENIN INHIBITION, CHRONIC KIDNEY-DISEASE, ASSIST DEVICE SUPPORT

ID: 15834811